BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 5, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Feb. 26, 2020

Feb. 26, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptas Solutions, Aidoc, Apple, Cryoport, Dana-Farber Cancer Institute, Fluidigm, Fresenius Medical Care North America, Inception Fertility, Instrunor, Iqvia, Johnson & Johnson, L3Harris Technologies, Lucidhealth, Neosync, Sophia Genetics, Stryker, Swittons, Twist Bioscience, Veeva, Wave Neuroscience, Wright Medical Group.
Read More

Other news to note for Feb. 26, 2020

Feb. 26, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arcus, Dialectic, Novavax, Promis, Pvp Biologics, Taiho, Takeda, Tonix.
Read More

Other news to note for Feb. 25, 2020

Feb. 25, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 1st Biotherapeutics, Arecor, Artizan, Astrazeneca, Atrin, Auris, Axovant, Certara, Daiichi Sankyo, Domainex, Dyadic, Excellerate, Immunos, In Silico, Index, Kahr, Lipocine, Lunac, Mallinckrodt, Moderna, Nektar, Omass, Oncologie, Peptilogics, Point Predictive Technology Group, Probiogen, Promis, Proteostasis, Redhill, Roche, Spring Bank, Tetra, Trianni, Twoxar, Vir, Wuxi.
Read More

Other news to note for Feb. 25, 2020

Feb. 25, 2020
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Aim Immunotech, Almirall, Alvogen Korea, Beijing Innocare, Beroni, Beximco, Cocrystal, Enlivex, Genetron Health, Glaxosmithkline, Hummingbird Bioscience, Immunoprecise Antibodies, Innovation, Medivir, Mesoblast, Molecular Templates, Mycenax, Mylan, Paratek, Sanofi, Shanghai Hile, Shijiazhuang Yuanmai, Sichuan Clover, Stonewise, Takeda, Viva, Vivus, Wuxi Biologics.
Read More

Other news to note for Feb. 25, 2020

Feb. 25, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adchim, Advion, American Brivision, Analog Devices, Artizan Biosciences, Beijing Bohui Innovation Biotechnology, Biomatrix, Bwx Technologies Certara, Cove, Ekso Bionics, Gerpang Healthcare Group, Gn Hearing, In Silico Biosciences, Interchim, International Health Technologies, Kindred Healthcare, Masimo, Miroculus, Milestone Scientific, Mologic, Ms Westfalia, Natus, Nemaura Medical, Pinpoint Science, Red One Medical, Redox, Resound, Siemens Healthineers, Theranica Bioelectronics, Trianni, Twist Bioscience, Welldoc.
Read More

Other news to note for Feb. 24, 2020

Feb. 24, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aiforia Technologies, Eurofins Discoverx, Innovative Forensic DNA, Intermed Group, Intermountain Forensics, Labcorp, Nanalysis Scientific, Perkinelmer, Proteostasis Therapeutic, Resolution Bioscience, RS2D, Shuwen Biotech, Sigma Imaging Technologies, Smith+Nephew, Spineovations, Velalabs.
Read More

Other news to note for Feb. 24, 2020

Feb. 24, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Allergan, Almirall, Anavex, Antibe, Beximco, BMS, Clover, Cocrystal, Cytomx, Enlivex, GSK, Innovation, Magenta, Medivir, Mylan, Paratek, Proteostasis, Rocket, Shijiazhuang Yuanmai, Viva.
Read More

Other news to note for Feb. 21, 2020

Feb. 21, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Co-Diagnostics, Erytech Pharma.
Read More

Other news to note for Feb. 21, 2020

Feb. 21, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aradigm, Arch, Beijing Innocare, Cyclica, Erytech, Genetron, Grifols.
Read More

Other news to note for Feb. 20, 2020

Feb. 20, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Oncotherapy, Allergan, Btl Industries, Cantel Medical, CMR Surgical, Cybermdx, Edmund Optics, Endonovo Therapeutics, Hu-Friedy, Icon, Inomec, Integer Holdings, Medpass International, Lantheus Holdings, Legion Healthcare Partners, Lexagene Holdings, Lexington Biosciences, Lucid Diagnostics, Medhub, Medlever, Moleculight, Neovasc, Pavmed, Progenics Pharmaceuticals.
Read More
Previous 1 2 … 367 368 369 370 371 372 373 374 375 … 1396 1397 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 4, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • Xray showing lung cancer on tablet

    How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III

    BioWorld
    Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing